AAAAAA
Results: 26-50/61
Authors:
HAGEMEISTER FB
Citation: Fb. Hagemeister, LOW-GRADE LYMPHOMAS - NEW ENTITIES AND TREATMENT CONCEPTS, Medical oncology, 12(3), 1995, pp. 131-142
Authors:
SUKI S
SWAN F
TUCKER S
FRITSCHE HA
REDMAN JR
RODRIGUEZ MA
MCLAUGHLIN P
ROMAGUERA J
HAGEMEISTER FB
VELASQUEZ WS
SARRIS AH
YOUNES A
CABANILLAS F
Citation: S. Suki et al., RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE, Leukemia & lymphoma, 18(1-2), 1995, pp. 87-92
Authors:
RODRIGUEZ MA
CABANILLAS FC
HAGEMEISTER FB
MCLAUGHLIN P
ROMAGUERA JE
SWAN F
VELASQUEZ W
Citation: Ma. Rodriguez et al., A PHASE-II TRIAL OF MESNA IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE FOR REFRACTORY LYMPHOMAS, Annals of oncology, 6(6), 1995, pp. 609-611
Authors:
RODRIGUEZ MA
CABANILLAS FC
VELASQUEZ W
HAGEMEISTER FB
MCLAUGHLIN P
SWAN F
ROMAGUERA JE
Citation: Ma. Rodriguez et al., RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP, Journal of clinical oncology, 13(7), 1995, pp. 1734-1741
Authors:
FULLER LM
KRASIN MJ
VELASQUEZ WS
ALLEN PK
MCLAUGHLIN P
RODRIGUEZ MA
HAGEMEISTER FB
SWAN F
CABANILLAS F
PALMER JL
COX JD
Citation: Lm. Fuller et al., SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 3-11
Authors:
DIAZPAVON JR
CABANILLAS F
MAJLIS A
HAGEMEISTER FB
Citation: Jr. Diazpavon et al., OUTCOME OF HODGKINS-DISEASE IN ELDERLY PATIENTS, Hematological oncology, 13(1), 1995, pp. 19-27
Authors:
STEINBACH G
CABANILLAS FF
PUGH W
GENTA R
GLOBER G
HAGEMEISTER FB
MCLAUGHLIN PW
RODRIGUEZ MA
ROMAGUERA JE
SARRIS AH
YOUNES A
JOHNSON C
KONISHI H
LYNCH PM
ROUBEIN LD
FORD R
GRAHAM DY
LEVIN B
Citation: G. Steinbach et al., ANTIBIOTIC-TREATMENT TRIAL OF GASTRIC MALT LYMPHOMA, Gastroenterology, 108(4), 1995, pp. 541-541
Authors:
HAGEMEISTER FB
MCLAUGHLIN P
RODRIGUEZ MA
COX JD
HA CS
ROMAGUERA JE
SARRIS A
YOUNES A
BACHIER C
PRETI A
CABANILLAS F
Citation: Fb. Hagemeister et al., THE PRETREATMENT SERUM BETA-2-MICROGLOBULIN (BETA(2)M) IS THE MOST IMPORTANT FEATURE PREDICTING FREEDOM FROM PROGRESSION (FFP) IN CLINICALLY STAGED (CS) I-II HODGKINS-DISEASE (HD) TREATED WITH NOVP AND EXTENDED FIELD RADIOTHERAPY, Blood, 86(10), 1995, pp. 2108-2108
Authors:
CABANILLAS F
LEE MS
MCLAUGHLIN P
HAGEMEISTER FB
COX JD
RODRIGUEZ MA
HA CS
ROMAGUERA JE
SARRIS A
YOUNES A
Citation: F. Cabanillas et al., EARLY ACHIEVEMENT OF MOLECULAR COMPLETE REMISSION (CR) ASSAYED BY PCRPREDICTS FAILURE FREE SURVIVAL (FFS) IN LOW-GRADE FOLLICULAR LYMPHOMAS (LGFL), Blood, 86(10), 1995, pp. 2405-2405
Authors:
HAGEMEISTER FB
Citation: Fb. Hagemeister, HODGKINS-DISEASE - CHALLENGES IN DIAGNOSIS, STAGING, AND TREATMENT, Diagnostic oncology, 4(1), 1994, pp. 33-47
Authors:
RODRIGUEZ J
PUGH WC
ROMAGUERA JE
LUTHRA R
HAGEMEISTER FB
MCLAUGHLIN P
RODRIGUEZ MA
SWAN F
CABANILLAS F
Citation: J. Rodriguez et al., PRIMARY MEDIASTINAL LARGE-CELL LYMPHOMA IS CHARACTERIZED BY AN INVERTED PATTERN OF LARGE TUMORAL MASS AND LOW BETA(2) MICROGLOBULIN LEVELS IN SERUM AND FREQUENTLY ELEVATED LEVELS OF SERUM LACTATE-DEHYDROGENASE, Annals of oncology, 5(9), 1994, pp. 847-849
Authors:
HAGEMEISTER FB
KHETAN R
ALLEN P
MCLAUGHLIN P
RODRIGUEZ MA
SWAN F
ROMAGUERA JE
CABANILLAS F
Citation: Fb. Hagemeister et al., STAGE, SERUM LDH, AND PERFORMANCE STATUS PREDICT DISEASE PROGRESSION AND SURVIVAL IN HIV-ASSOCIATED LYMPHOMAS, Annals of oncology, 5, 1994, pp. 190000041-190000046
Authors:
HAGEMEISTER FB
PURUGGANAN R
PODOLOFF DA
HESS M
RODRIGUEZ MA
MCLAUGHLIN P
SWAN F
ROMAGUERA JE
CABANILLAS F
Citation: Fb. Hagemeister et al., THE GALLIUM SCAN PREDICTS RELAPSE IN PATIENTS WITH HODGKINS-DISEASE TREATED WITH COMBINED-MODALITY THERAPY, Annals of oncology, 5, 1994, pp. 190000059-190000063
Authors:
MCLAUGHLIN P
HAGEMEISTER FB
SWAN F
CABANILLAS F
ROMAGUERA J
RODRIGUEZ MA
LEE MS
PATE O
SARRIS A
YOUNES A
Citation: P. Mclaughlin et al., INTENSIVE CONVENTIONAL-DOSE CHEMOTHERAPY FOR STAGE-IV LOW-GRADE LYMPHOMA - HIGH REMISSION RATES AND REVERSION TO NEGATIVE OF PERIPHERAL-BLOOD BCL-2 REARRANGEMENT, Annals of oncology, 5, 1994, pp. 190000073-190000077
Authors:
PRETI A
HAGEMEISTER FB
MCLAUGHLIN P
SWAN F
RODRIGUEZ A
BESA P
COX JD
ALLEN PK
CABANILLAS F
Citation: A. Preti et al., HODGKINS-DISEASE WITH A MEDIASTINAL MASS GREATER-THAN 10 CM - RESULTSOF 4 DIFFERENT TREATMENT APPROACHES, Annals of oncology, 5, 1994, pp. 190000097-190000100
Authors:
VELASQUEZ WS
MCLAUGHLIN P
TUCKER S
HAGEMEISTER FB
SWAN F
RODRIGUEZ MA
ROMAGUERA J
RUBENSTEIN E
CABANILLAS F
Citation: Ws. Velasquez et al., ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY, Journal of clinical oncology, 12(6), 1994, pp. 1169-1176
Authors:
MCLAUGHLIN P
HAGEMEISTER FB
SWAN F
CABANILLAS F
PATE O
ROMAGUERA JE
RODRIGUEZ MA
REDMAN JR
KEATING M
Citation: P. Mclaughlin et al., PHASE-I STUDY OF THE COMBINATION OF FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE IN LOW-GRADE LYMPHOMA, Journal of clinical oncology, 12(3), 1994, pp. 575-579
Authors:
ROMAGUERA JE
RODRIGUEZ MA
HAGEMEISTER FB
MCLAUGHLIN P
SWAN F
MOORE DF
SARRIS AH
YOUNES A
HILL D
CABANILLAS F
Citation: Je. Romaguera et al., A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/, Investigational new drugs, 12(3), 1994, pp. 217-222
Authors:
KIM EE
GARCIA JR
WONG FCL
HAGEMEISTER FB
WONG WH
HAYNIE TP
YANG DJ
PODOLOFF DA
Citation: Ee. Kim et al., DIFFERENTIATION OF BONE LYMPHOMA FROM POSTTREATMENT CHANGES USING PETWITH F-18 FDG, The Journal of nuclear medicine, 35(5), 1994, pp. 160000035-160000035
Authors:
GARCIA JR
KIM EE
WONG FCL
HAGEMEISTER FB
HAYNIE TP
WONG WH
YANG DJ
PODOLOFF DA
Citation: Jr. Garcia et al., GA-67-CITRATE SCAN IN THE DIFFERENTIATION OF BONE LYMPHOMA FROM POSTTREATMENT CHANGES - COMPARISON WITH FDG-PET SCAN, The Journal of nuclear medicine, 35(5), 1994, pp. 160000131-160000131
Authors:
HAGEMEISTER FB
PURUGGANAN R
FULLER L
MCLAUGHLIN P
SWAN F
ROMAGUERA J
RODRIGUEZ M
CABANILLAS F
Citation: Fb. Hagemeister et al., TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY, Seminars in hematology, 31(2), 1994, pp. 36-43
Authors:
VELASQUEZ WS
MCLAUGHLIN P
FULLER LM
ALLEN PK
TUCKER SL
SWAN F
RODRIGUEZ MA
HAGEMEISTER FB
CABANILLAS FF
Citation: Ws. Velasquez et al., INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS, Cancer, 73(9), 1994, pp. 2408-2416
DYSREGULATED VITAMIN-D METABOLISM IS COMMON IN NORMOCALCEMIC PATIENTSWITH UNTREATED HODGKINS-DISEASE
Authors:
SEYMOUR JR
GAGEL RF
HAGEMEISTER FB
CABANILLAS F
Citation: Jr. Seymour et al., DYSREGULATED VITAMIN-D METABOLISM IS COMMON IN NORMOCALCEMIC PATIENTSWITH UNTREATED HODGKINS-DISEASE, Blood, 84(10), 1994, pp. 10000158-10000158
Authors:
MOORE DF
HAGEMEISTER FB
RODRIGUEZ MA
ROMAGUERA JE
MCLAUGHLIN P
CABANILLAS F
FULLER L
Citation: Df. Moore et al., CLINICAL CHARACTERISTICS AND OUTCOME OF HODGKINS-DISEASE (HD) IN 125 PATIENTS (PT) 60 YEARS OF AGE AND OLDER, Blood, 84(10), 1994, pp. 10000163-10000163
Authors:
HAGEMEISTER FB
DUNLAVY K
CROW M
SANFORD D
KATZ R
Citation: Fb. Hagemeister et al., FINE-NEEDLE ASPIRATION (FNA) IN THE MANAGEMENT OF PATIENTS (PT) WITH HODGKINS-DISEASE (HD), Blood, 84(10), 1994, pp. 10000642-10000642